Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC392

Eptinezumab

  • Status:
    Veitt
  • Application date:
    15.6.2022
  • Application published:
    15.7.2022
  • Grant published:
    15.2.2024
  • Max expiry date:
    24.1.2037
  • Medicine name:
    Vyepti
  • Medicine for children:
    No

Timeline

Today
15.6.2022Application
15.7.2022Publication
15.2.2024Registration
24.1.2037Expires

Marketing license

  • IS authorization number:
    EU/1/21/1599/001
  • Date:
    28.1.2022
  • Foreign authorization number:
    EU/1/21/1599
  • Date:
    24.1.2022

Owner

  • Name:
    H. Lundbeck A/S
  • Address:
    Ottiliavej 9, Valby DK

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 09.02.2024

Upload documents